RevelAi Health and Zimmer Biomet Holdings announced a multi-year co-marketing agreement to commercialize generative artificial intelligence-powered engagement solutions that advance value-based orthopedic care and health equity. During the multi-year agreement, Zimmer Biomet will commercialize RevelAi Health’s patient care-management platform, care team dashboard for providers, and any future products or services.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet signs agreement with THINK Surgical for robotic solution
- Zimmer Biomet price target lowered to $125 from $130 at Barclays
- PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
- Zimmer Biomet initiated with a Neutral at Goldman Sachs
- Zimmer Biomet formalizes partnership with CBRE